Isoxsuprine HCl Plus MgSO4 for Preterm Labor: Not Recommended
The combination of isoxsuprine hydrochloride with magnesium sulfate for preterm labor is not supported by current evidence and should be avoided. Neither drug is recommended as a first-line tocolytic agent, and magnesium sulfate is explicitly labeled as an unapproved treatment for preterm labor by the FDA.
Critical FDA Warning on Magnesium Sulfate
The FDA drug label is unequivocal: "Continuous administration of magnesium sulfate is an unapproved treatment for preterm labor. The safety and efficacy of such use have not been established." 1 This directly addresses your question - magnesium sulfate should not be used as a tocolytic agent for stopping preterm labor.
FDA Pregnancy Category D Warning
MgSO4 carries serious fetal risks when used beyond 5-7 days, including:
- Hypocalcemia
- Skeletal demineralization and osteopenia
- Neonatal fractures
- Bone abnormalities 1
The FDA explicitly states that magnesium sulfate should only be used during pregnancy "if clearly needed" and warns that prolonged use can cause fetal harm 1.
Appropriate Uses of Magnesium Sulfate (Not Tocolysis)
ACOG and SMFM support short-term use (usually <48 hours) of magnesium sulfate for three specific indications 2, 3:
- Prevention and treatment of eclamptic seizures in preeclampsia/eclampsia
- Fetal neuroprotection before anticipated early preterm delivery (<32 weeks gestation)
- Short-term pregnancy prolongation (up to 48 hours) to allow antenatal corticosteroid administration
None of these indications involve using MgSO4 as a tocolytic to stop contractions.
Isoxsuprine: Limited Evidence and Not Standard of Care
While some research suggests isoxsuprine may have tocolytic effects 4, 5, it is not part of standard obstetric guidelines or recommended by major professional societies. The evidence base consists primarily of older studies and lacks the robust support needed for routine clinical use.
Key Problems with Isoxsuprine:
- Not mentioned in current SMFM or ACOG guidelines
- Limited high-quality randomized controlled trial data
- Not a first-line tocolytic in modern obstetric practice
- Maternal side effects include tachycardia and vomiting 4
Drug Interaction Concerns
The FDA label specifically warns about combining magnesium sulfate with CNS depressants, stating: "When barbiturates, narcotics or other hypnotics (or systemic anesthetics), or other CNS depressants are to be given in conjunction with magnesium, their dosage should be adjusted with caution because of additive CNS depressant effects." 1
While isoxsuprine is not specifically a CNS depressant, combining two agents with cardiovascular effects (isoxsuprine causes tachycardia; magnesium affects cardiac conduction) raises safety concerns without established benefit.
Clinical Bottom Line
Do not use this combination. If tocolysis is needed:
- Use evidence-based first-line tocolytics (nifedipine or indomethacin, depending on gestational age)
- Reserve magnesium sulfate exclusively for its approved indications: fetal neuroprotection before imminent preterm delivery <32 weeks, or seizure prophylaxis/treatment in preeclampsia
- If using MgSO4 for fetal neuroprotection, standard dosing is 4g IV bolus followed by 1g/hour maintenance for up to 24 hours 2, 3
Critical Monitoring if MgSO4 is Used (for approved indications only):
- Patellar reflexes before each dose
- Respiratory rate (maintain ≥16 breaths/min)
- Urine output (≥100 mL per 4 hours)
- Serum magnesium levels (therapeutic range 2.5-5 mEq/L)
- Have calcium gluconate immediately available as antidote 1
The combination you're asking about represents off-label use of both medications without supporting evidence and should not be employed in clinical practice.